Selected Publications

Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Leahy AB, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM.: Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Adv 9: 354-359, Jan 2025.

Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL.: Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood 144: 1387-1398, Sep 2024.

Myers RM, Devine K, Li Y, Lawrence S, Leahy AB, Liu H, Vernau L, Callahan C, Baniewicz D, Kadauke S, McGuire R, Wertheim GB, Kulikovskaya I, Gonzalez VE, Fraietta JA, DiNofia AM, Hunger SP, Rheingold SR, Aplenc R, June CH, Grupp SA, Wray L, Maude SL.: Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood Adv 8: 2182-2192, May 2024.

Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS.: Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol 15: 1369243, Feb 2024.

Elgarten CW, Heidemann S, Freedman JL, Grupp SA, Hankins P, Kadauke S, Li Y, McGlynn B, Olson TS, Wang Y, Wray L, Wang L, Seif AE, Bunin NJ: Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies Transplantation and Cellular Therapy 30(2): S9-S10, Feb 2024.

Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman JL, Wang Y, Kadauke S, Hankins P, Nicholas P, Worster E, Kwiatkowski JL, Grupp SA, Bunin NJ, Olson TS: Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies. Transplantation and Cellular Therapy 30(2): S301-S302, Feb 2024.

Myers RM, Mumanachit S, Maude SL, Dinofia AM, Freedman JL, Bunin N, Wray L, Barz AL, Olson TS, Grupp S, Seif AE, Elgarten CW: 3767 Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia. American Society of Hematology December 2023.

Freedman J, Phillips C, Wray L, Smith L, McGuire R, Bailer J: Enteral Nutrition Post Pediatric Hematopoietic Stem Cell Transplant. Multinational Association of Supportive Care in Cancer/JASCC/ISOO June 2023.

Newman H, Li Y, Liu H, Myers RM, Tam V, DiNofia A, Wray L, Rheingold SR, Callahan C, White C, Baniewicz D, Winestone LE, Kadauke S, Diorio C, June CH, Getz KD, Aplenc R, Teachey DT, Maude SL, Grupp SA, Bona K, Leahy AB.: Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood 141: 609-619, Feb 2023.

Fraint E, Abdel-Azim H, Bhatt N, Broglie L, Chattha A, Kohorst M, Ktena Y, Lee M, Long S, Qayed M, Sharma A, Stefanski H, Vatsayan A, Wray L, Hamadani M, Carpenter P: Evaluation of children with malignancies for blood and marrow transplantation: A report from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy Page: doi: 10.1016, February 2023 Notes: epub ahead of print.